Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 1 13Phase 1/2 11Phase 2 9Phase 3 6Phase 2/3 2Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 8Neoplasms 6Stomach Neoplasms 5Prostatic Neoplasms 5Lung Neoplasms 5Head and Neck Neoplasms 5Oropharyngeal Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Fatigue 4Urinary Bladder Neoplasms 3Recurrence 3Ovarian Neoplasms 3Neoplasm Metastasis 3Myasthenia Gravis 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Colorectal Neoplasms 3Weight Loss 2Peritoneal Neoplasms 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Squamous Cell 2

Interventions

Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × 30 days × Clear all
NCT07462143 2026-05-22

A Phase â…¡/â…¢ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

RemeGen Co., Ltd.

Phase 2/3 Recruiting
80 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05174169 2026-05-06

CIRCULATE-US

NRG Oncology

Phase 2/3 Recruiting
1,912 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡